B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. [electronic resource]
Producer: 20080219Description: 676-88 p. digitalISSN:- 1533-4406
- Adolescent
- Adult
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Murine-Derived
- Antigens, CD20
- B-Lymphocytes -- drug effects
- Brain -- pathology
- Double-Blind Method
- Female
- Gadolinium
- Humans
- Immunoglobulins -- blood
- Immunologic Factors -- adverse effects
- Infusions, Intravenous
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Remission Induction
- Rituximab
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.